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Abstract
To evaluate the role of cellular infiltrates in CNS demyelination in immunocompetent mice, we have used a model of
multiple sclerosis (MS) in which different strains of mice are infected with a recombinant HSV-1 expressing IL-2. Histologic
examination of the mice infected with HSV-IL-2 demonstrates that natural killer cells, dendritic cells, B cells, and CD25 (IL-
2ra) do not play any role in the HSV-IL-2-induced demyelination. T cell depletion, T cell knockout and T cell adoptive transfer
experiments suggest that both CD8
+ and CD4
+ T cells contribute to HSV-IL-2-induced CNS demyelination with CD8
+ T cells
being the primary inducers. In the adoptive transfer studies, all of the transferred T cells irrespective of their CD25 status at
the time of transfer were positive for expression of FoxP3 and depletion of FoxP3 blocked CNS demyelination by HSV-IL-2.
The expression levels of IL-12p35 relative to IL-12p40 differed in BM-derived macrophages infected with HSV-IL-2 from those
infected with wild-type HSV-1. HSV-IL-2-induced demyelination was blocked by injecting HSV-IL-2-infected mice with IL-
12p70 DNA. This study demonstrates that suppression of the IL-12p70 function of macrophages by IL-2 causes T cells to
become auto-aggressive. Interruption of this immunoregulatory axis results in demyelination of the optic nerve, the spinal
cord and the brain by autoreactive T cells in the HSV-IL-2 mouse model of MS.
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Introduction
Epidemiologic studies have implicated genetic, as well as
environmental factors, in the development of multiple sclerosis
(MS) [1,2]. The possibility that infectious agents, particularly
viruses, are involved [3,4] remains controversial [5,6,7] and the
evidence suggests that if an infectious agent is involved, it alone
may not be sufficient to initiate the observed pathology [5,6,7].
There are several lines of evidence implicating the cytokine,
interleukin-2 (IL-2) in the pathology of MS [8,9,10,11]. Patients
with MS have elevated levels of IL-2 in their cerebrospinal fluid
(CSF) and sera and IL-2-deficient mice are more resistant to
experimental autoimmune encephalitis (EAE) than their hetero-
zygote and wild-type counterparts [12]. To explore the possibility
that IL-2 may play a role in the pathology of MS in conjunction
with viral infection, we constructed a recombinant herpes simplex
virus type 1 (HSV-1) that expresses murine IL-2 constitutively [13]
as well as a panel of control recombinant viruses that express
murine IL-4, interferon (IFN)-c, IL-12p35, or IL-12p40 contin-
uously [14,15,16]. We have shown previously that ocular infection
of different strains of mice (i.e., BALB/c, C57BL/6, SJL/6, and
129SVE) with the HSV-IL-2 virus results in demyelination of the
optic nerves (ON), the spinal cords (SC) and the brains of the
infected mice as determined by histologic examination of tissues
obtained at necropsy [17,18]. The demyelinated lesions involved
the periventricular white matter, brain stem, and SC white matter,
and had striking similarities to the plaques seen in patients with
MS [17]. Demyelination was detected in the CNS of infected mice
up to 75 days (the longest time point tested) post HSV-IL-2
infection. However, the severity of demyelination did not increase
from 14 days to 75 days post infection. In addition, the HSV-IL-2
infected mice developed optic neuropathy as determined by
changes in the visual-evoked cortical potentials (VECPs) [18]. In
contrast, demyelination was not detectable after infection of the
mice with wild-type (wt) HSV-1 alone or infection of the mice with
the HSV-IL-4 or HSV-IFN-c viruses, which are identical to HSV-
IL-2 except that they express IL-4 or IFN-c instead of IL-2
[17,18].
The pathogenic processes that underlie demyelination in MS
have not yet been elucidated. One hypothesis is that autoimmunity
to CNS antigens is triggered by environmental factors in
genetically susceptible individuals and that the activated immune
response leads to destruction of the myelin [1,2]. Our published
studies suggest that HSV plays an important role in initiating
destruction of the myelin in the presence of elevated levels of IL-2.
Thus, the HSV-IL-2-induced demyelination could be associated
with the innate or the adaptive arms of the immune response in
the infected mice. Therefore, we undertook the current studies to
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2ra (CD25), CD4
+ T cells, and CD8
+ T cells in the HSV-IL2-
induced CNS demyelination. The results indicate that the
demyelinated lesions observed after infection with HSV-IL-2 are
associated with both CD4
+ and CD8
+ T cells, with CD8
+ T cells
playing the more prominent role. Furthermore, the demyelination
was found to be associated with IL-2-mediated suppression of IL-
12p70 expression by macrophages. The expression of IL-12p70 in
the macrophages in the presence of IL-2 was restored by co-
infection of mice with recombinant HSV-IL-12p70 virus, which
also prevented demyelination. Thus, IL-12p70 expression by
macrophages can act to regulate induction of T-cell autoimmune
disease. Our results suggest a potential mechanism for the
association of higher levels of IL-2 expression with susceptibility
to MS, in which the IL-2 inhibits the ability of the macrophages to
suppress an autoimmune T-cell response to infection with
neurotropic viruses.
Results
Role of B cells, DCs, and NK cells in HSV-IL-2 induced
demyelination in infected mice
To determine the possible involvement of innate immunity in the
regulation of HSV-IL-2-induced demyelination in the present
study, we used B-cell deficient mice (BALB/c-CD19
2/2), BALB/
c-DTR transgenic mice (CD11c-diphtheria toxin receptor-GFP)
that were depleted of DCs using DT, and C57BL/6 mice that were
depleted of NK cells using anti-asialo GM1 monoclonal antibodies.
All of the mice, including the female BALB/c-CD19
2/2, control
BALB/c, BALB/c-DTR transgenic mice with and without DC
depletion,andC57BL/6micewithand withoutNKdepletion,were
infected ocularly with either HSV-IL-2 or HSV-IL-4. At day 14 PI,
the mice were sacrificed and the ONs collected post-fixed and
stained with the myelin stain, LFB. Representative photomicro-
graphs of the ON sections from mice infected with HSV-IL-2 or
HSV-IL-4 are shown in Figure 1.
Demyelination was observed in the HSV-IL-2-infected BALB/
c-DTR mice that had been depleted of their DCs (Fig. 1A) but not
in the HSV-IL-4-infected BALB/c-DTR mice that had been
depleted of their DCs (Fig. 1B). Similarly, demyelination of the
ON was observed in HSV-IL-2-infected mice that had been
depleted of their NK cells (Fig. 1C) but not in NK-depleted mice
following ocular infection with HSV-IL-4 (Fig. 1D).
Finally, demyelination of the ON was observed in the HSV-IL-
2-infected BALB/c-CD19
2/2 mice (Fig. 1E), but not in the HSV-
IL-4-infected BALB/c-CD19
2/2 mice (Fig. 1F). The patterns of
demyelination of the ON in the absence of DCs, NK cells, or B
cells were similar to the patterns of demyelination observed in wt
mice infected with HSV-IL-2 (data not shown). Similar results
were obtained with regards to demyelination in the SC and brains
of the infected mice (data not shown). The failure of depletion of
the cells to block the HSV-IL-2-induced demyelination suggests
that B cells, NK cells, and DCs do not contribute to the
demyelination of the ON in this mouse model. As the depletion
did not result in exacerbation of the demyelination, the results also
suggest that these components of the innate immune response do
not act to suppress the autoimmune response. We have observed
that the absence of macrophages exacerbates HSV-IL-2-induced
demyelination and that even wt HSV-1 induces demyelination in
infected BALB/c or C57BL/6 mice in the absence of macro-
phages (data not shown), which suggests that macrophages are not
required for the development of the autoreactive demyelinating
response, but may act to suppress it, as discussed in detail below.
Role of T cells in HSV-IL-2-induced demyelination
To determine whether T cells contribute to the HSV-IL-2-
induced demyelination, BALB/c mice were depleted of CD4
+ and
CD8
+ cells and infected ocularly with HSV-IL-2 or control HSV-
IL-4. Demyelination was not detectable in ON, brain, or SC of
BALB/c mice depleted of both CD4
+ and CD8
+ T cells and
infected ocularly with HSV-IL-2 (Fig. 2, Panels A, B, C). Similarly,
demyelination was not detectable in C57BL/6 mice depleted of
Figure 1. Role of innate immunity in HSV-IL-2 induced CNS demyelination. Female BALB/c-CD19
2/2, BALB/c-DTR transgenic mice, and NK-
depleted C57BL/6 mice were infected ocularly with HSV-IL-2 or HSV-IL-4 as described in Materials and Methods. On day 14 PI, ON were collected,
fixed, sectioned, and stained with LFB. Representative photomicrographs are shown. Arrows indicate areas of demyelination.
doi:10.1371/journal.pone.0016820.g001
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+ and CD8
+ cells and infected ocularly with HSV-IL-2
(data not shown). As expected mice of either strain that were
depleted of CD4
+ and CD8
+ T cells and infected with HSV-IL-4
rather than HSV-IL-2 showed no sign of demyelination in ON
(Fig. 2, Panels D, E, and F). These results suggested that, as has
been described in MS and other models of MS [19,20,21], T cells
do contribute to the HSV-IL-2-induced demyelination.
HSV-IL-2-infection of the BALB/c mice that had been depleted
of their CD4
+ T cells, but not their CD8
+ cells, resulted in
demyelination in the ON, SC, and brain, which was detected as
the pale blue area in LFB staining (Fig. 2, Arrows, Panels G, H,
and I). Similarly, HSV-IL-2 infection of mice that had been
depleted of their CD8
+ T cells but not their CD4
+ cells, resulted in
demyelination in their ON, SC, and brain (Fig. 2, arrows; Panels J,
K, and L). As expected neither CD4-depleted nor CD8-depleted
mice infected with HSV-IL-4 showed any signs of demyelination
(Fig. 2, Panels M-R). Similar results were obtained when C57BL/6
mice were depleted of their CD4
+ T cells alone or CD8
+ T cells
alone and infected ocularly with HSV-IL-2 or control HSV-IL-4
(data not shown). As depletion of both CD4
+ and CD8
+ T cells
prevented the HSV-IL-2-induced demyelination, these results
suggest that both CD4
+ and CD8
+ T cells contribute to the CNS
demyelination. To verify these results, we analyzed demyelination
in CD4 (C57BL/6-CD4
2/2) and CD8 (C57BL/6-CD8
2/2)
knockout mice. Demyelination was observed in the ON, SC,
and brain of the CD4 knockout mice infected with HSV-IL-2
(Fig. 3, CD4
2/2) and the ON, SC, and brain of the CD8 knockout
mice infected with HSV-IL-2 (Fig. 3, CD8
2/2). No demyelination
was observed in ON, SC, and brain of CD4 knockout mice (Fig. 3,
CD4
2/2) or CD8 knockout mice infected with HSV-IL-4 (Fig. 3,
CD4
2/2). Collectively, these data strongly implicate both CD4
+
and CD8
+ T cells in HSV-IL-2-induced CNS demyelination.
We noted that the severity of the HSV-IL-2-induced
demyelination appeared to be greater in the presence of CD8
+
T cells (in the CD4 knockout mice) than in the presence of CD4
+
T cells (in the CD8 knockout mice) (Fig. 3). Thus, to determine if
more plaques are present in the CNS of CD4-knockout mice as
compared with their CD8-knockout counterparts or wt C57BL/6
mice, we counted the number of observed plaques in the ON, SC
and brain of CD4
2/2,C D 8
2/2, and wt control mice. The data
are shown as the number of sections showing demyelination
plaques per total stained sections counted in Figure S1. More
plaques were detected in the brains of both the HSV-IL-2-
infected CD4- and CD8-knockout mice than in the brains of the
HSV-IL-2-infected wt mice, but these differences were only
significantwhen the numbers of plaques inthebrains of theCD4-
knockout mice were compared with the numbers in the brains of
the wt mice (Figure S1-A; Brain; p,0.05). The number of HSV-
IL-2-induced plaques detected in the SC were significantly
higher in both the CD4- and CD8- knockout mice as compared
with the numbers of plaques in the SC of wt mice (Figure S1-A,
SC). In contrast, No significant differences were observed in the
number of HSV-IL-2-induced plaques detected in ON of the
knockout mice and the wt control mice (Figure S1-A, ON).
Overall, more HSV-IL-2-induced demyelination plaques were
detected in the SC of the knockout mice than their ON or brain
Figure 2. Demyelination in T cells-depleted mice. Mice were infected ocularly with HSV-IL-2 or HSV-IL-4. Forty-eight hr prior to infection, and
on days 1, 5, and 9 days PI mice were depleted of CD4
+ T cell, CD8
+ T cell, or both T cell populations as described in Materials and Methods. After 14
days, brains, SC, and ON were removed, sectioned, and stained for LFB. Arrows indicate areas of demyelination in ON, SC, and brains of HSV-IL-2
infected mice.
doi:10.1371/journal.pone.0016820.g002
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ON of depleted and mock-depleted BALB/c mice are presented
in Figure 1B (Figure S1-B). Similar to knockout mice, more
plaques were present in the CNS of CD4-depleted mice compare
with their CD8-depleted counterparts but these differences did
not reach statistical significance compared with the number of
plaques in the mock-depleted control mice (Figure S1-B). As
anticipated, the CD4-, CD8-, or mock-depleted groups of mice
had significantly higher number of plaques than mice that were
depleted of both CD4
+ and CD8
+ T cells (Figure S1-B) Thus, our
CD4 and CD8 knockout studies suggest that both CD4 and CD8
T cells contribute to CNS demyelination and in the absence of
t h em i s s i n gTc e l ls u b s e tt h el e v e lof demyelination is increased in
HSV-IL-2 infected mice.
Role of natural and HSV-IL-2-induced T cells in CNS
demyelination
As the above results suggested that not only are both CD4
+
and CD8
+ Tc e l l sa r ei n v o l v e di nC N Sd e m y e l i n a t i o nb u tt h a t
CD8
+ T cells play a more prominent role (Figures 2, 3), we
extended the studies to differentiate between responses of CD4
+
or CD8
+ n a i v eTc e l l sv e r s e se f f e c t o r sTc e l l si nC N S
demyelination. CD4
+CD25
+,C D 4
+CD25
2,C D 8
+CD25
+,a n d
CD8
+CD25
2 T cells were isolated using magnetic beads from
naive BALB/c mice (naive T cell, nT cell) or BALB/c mice
infected ocularly with HSV-IL-2 (effector T cell, effT cell) and
the cells injected intraperitoneally into BALB/c-SCID recipient
mice. Four hours after adoptive transfer, all of the SCID
recipient mice were infected ocularly with HSV-IL-2 or HSV-1
strain KOS. Control SCID mice that received tissue culture
media only also were infected ocularly with HSV-IL-2 or KOS.
Fourteen days after infection, the mice were sacrificed and the
SC removed, post-fixed and stained with LFB. Representative
photomicrographs are shown in Figure 4 and a summary of the
data concerning the demyelination of the SC sections from
mice infected with HSV-IL-2 or HSV-1 KOS is shown in
Table 1.
We found that demyelination was undetectable in the mice that
received nCD4
+CD25
+ T cells prior to infection with HSV-IL-2
(Fig. 4, HSV-IL-2), whereas demyelination occurred in the mice
that received nCD4
+CD25
2 T cells prior to infection (Fig. 4,
HSV-IL-2, arrow). Demyelination was detectable in mice that
received either nCD8
+CD25
+ or nCD8
+CD25
2 prior to infection
with HSV-IL-2 virus (Fig. 4, HSV-IL-2, arrows). There were no
signs of demyelination in KOS-infected mice that received
nCD4
+CD25
+, nCD4
+CD25
2, nCD8
+CD25
+, or nCD8
+CD25
2
T cells (Fig. 4, KOS).
In contrast, demyelination in the SC was observed in all SCID
mice that received effCD4
+CD25
+, effCD4
+CD25
2, effCD8
+
CD25
+, or effCD8
+CD25
2 T cells and were infected with HSV-
IL-2 (Fig. 4, HSV-IL-2, arrows). Demyelination was not observed
in mice that received effCD4
+CD25
+ T cells and were infected
with KOS (Fig. 4, KOS), although mice that received
effCD4
+CD25
2, effCD8
+CD25
+, or effCD8
+CD25
2 T cells and
were infected with KOS developed demyelination (Fig. 4, KOS,
arrows). As expected SCID mice that received induced T cells but
Figure 3. Demyelination in T cells-knockout mice. CD4
2/2 and CD8
2/2 mice were infected ocularly with HSV-IL-2 or HSV-IL-4 as described in
Materials and Methods. After 14 days, ON, SC, and brains were removed, sectioned, and stained for LFB. Arrows indicate areas of demyelination in ON,
SC, and brain of HSV-IL-2 infected mice.
doi:10.1371/journal.pone.0016820.g003
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demyelination (data not shown). Furthermore, SCID mice that
received media without T cells prior to infection with HSV-IL-2 or
KOS did not develop any demyelination (Table 1). The patterns of
demyelination in the brain and ON of the different groups of
infected mice were similar to the patterns of demyelination in the
SC described above (data not shown). The results of these studies
provide further evidence that both CD4
+ and CD8
+ T cells
contribute to CNS demyelination with CD8
+ T cells playing a
more prominent role than CD4
+ T cells.
Figure 4. Adoptive transfer of naive and effector T cells to SCID mice. Naive T cells (nCD8
+CD25
+, nCD8
+CD25
2, nCD4
+CD25
+, and
nCD4
+CD25
2) were isolated from naive mice, while the effector T cells (effCD8
+CD25
+, effCD8
+CD25
2, effCD4
+CD25
+, and effCD4
+CD25
2) were
isolated from mice infected with HSV-IL-2 on day 5 PI. Magnetically isolated cells were transferred IP into recipient SCID mice and 4hr post-adoptive
transfer, recipient SCID mice were infected ocularly with HSV-IL-2 or WT HSV-1 strain KOS. Representative ON sections on day 14 PI from infected mice
are shown. Arrows indicate areas of demyelination.
doi:10.1371/journal.pone.0016820.g004
Macrophages and CNS Demyelination by HSV-IL-2
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The results described above (Fig. 5) suggested that both CD25
+
and CD25
2 T cells can induce CNS demyelination in SCID mice
that are infected with HSV-IL-2. To determine if the transferred T
cells are expressing FoxP3, we measured FoxP3 transcripts by
qRT-PCR using total RNA isolated from the brains of the mice
described above and in Figure 5 that were sacrificed on day 14 PI.
FoxP3 transcripts were found in the brains of the mice that
received nCD4
+CD25
+, nCD4
+CD25
2, effCD4
+CD25
+,o r
effCD4
+CD25
2 cells and were infected with HSV-IL-2, and the
mice that received effCD4
+CD25
+ or effCD4
+CD25
2 cells and
were infected with KOS (Fig. 5A). The levels of the Foxp3
transcripts were similar in all the groups of mice irrespective of the
CD25 status of the transferred cells (Fig. 5A). No differences in the
expression of the CD4 transcript were observed among the groups
(data not shown). Similarly, FoxP3 transcripts were observed in the
brains of the mice that received nCD8
+CD25
+, nCD8
+CD25
2,
effCD8
+CD25
+, or effCD8
+CD25
2 and were infected with
HSV-IL-2, and the mice that received effCD8
+CD25
+ or
effCD8
+CD25
2 and were infected with KOS (Fig. 5B). The
expression of CD8 transcript was similar among these groups and
statistically significant differences were not observed (data not
shown). Similar level of FoxP3 transcript was detected in the
isolated T cell population before transfer (not shown). Collectively,
these results suggest that both the CD25
+ and CD25
2 T cells
expressed FoxP3 transcripts and that the transferred T cells may
have a Treg rather then a Teff phenotype. Previously it was
reported that FoxP3 is a better indicator of Treg cell linage
specification factor than CD25 [22,23].
Role of FoxP3 in HSV-IL-2-induced demyelination
Our qRT-PCR analyses described above (Fig. 5) suggested that
all transferred T cells irrespective of presence or absence of CD25
had similar levels of FoxP3 transcript in the brain of recipient
SCID mice suggesting that FoxP3 may play a role in HSV-IL-2-
induced CNS demyelination. To determine whether FoxP3
contributed to the HSV-IL-2-induced demyelination, FoxP3
DTR
mice were depleted of FoxP3 using diphtheria toxin and infected
ocularly with HSV-IL-2 or control HSV-IL-4. Demyelination was
not detectable in ON, SC or brain of FoxP3 depleted mice
infected ocularly with HSV-IL-2 (Fig. 6, Left Panels). However,
demyelination was detected in CNS of mice that were mock-
depleted and infected with HSV-IL-2 (Fig. 6, Middle Panels). As
expected mice of that were mock-depleted and infected with HSV-
IL-4 rather than HSV-IL-2 showed no sign of demyelination in
ON, brain, or SC (Fig. 6, Right Panels). These results suggested
that, FoxP3-positive T cells contribute to the HSV-IL-2-induced
demyelination.
Effect of endogenous IL-2 on the outcome of HSV-IL-2
infection
Previously we have shown that splenocytes from mice infected
with HSV-IL-2 induced a TH0/TC0 type of immune response
during early phase of infection suggesting that the host IL-2 may
contribute to demyelination [13,17]. Moreover, our confocal
microscopic analyses of double-stained brain sections from HSV-
IL-2-infected mice suggested the presence of both exogenous IL-2
(produced by HSV-IL-2) and endogenous IL-2 (produced by host)
[17]. To assess the possible involvement of host IL-2 in the HSV-
IL-2-induced demyelination, we used BALB/c-STAT4
2/2 mice,
which do not mount a TH1 response, and BALB/c-STAT6
2/2
mice, which do not mount a TH2 response. Mice were infected
ocularly with 2610
5 PFU/eye of HSV-IL-2 or HSV-IL-4,
sacrificed at day 14 PI and the ON, brain, and SC dissected
and stained with LFB. Control wt BALB/c mice were infected
similarly with HSV-IL-2 or HSV-IL-4. Representative photomi-
crographs of are shown in Figure 7. Demyelination was observed
in the ON, SC, and brain of both STAT4
2/2 and STAT6
2/2
mice (Fig. 7, Left Panels, arrows). No such lesions or other signs of
demyelination were observed in the ON, SC, and brain of either
STAT4
2/2 or STAT6
2/2 mice infected with HSV-IL-4 (Fig. 7,
Right Panels). Overall, more demyelination was detected in the
SC of the STAT4
2/2 and STAT6
2/2 mice infected with HSV-
IL-2 than in their brain or ON (Fig. 6, HSV-IL-2, Left panels).
Similar results were obtained upon infection of wt BALB/c mice
(data not shown). Thus, these results suggest that endogenously
produced TH1 and TH2 cytokines did not contribute to CNS
demyelination.
Role of CD25 (IL-2ra) in HSV-IL-2-induced demyelination
CD25, also known as IL-2ra, is a component of the high-affinity
IL-2R, which increases the sensitivity of the receptor for IL-2 by
more than 100-fold [24,25]. Our transfer studies suggest that
CD25 does not play any role in the HSV-IL-2-induced
demyelination. To further determine the lack of CD25 involve-
ment in HSV-IL-2-induced demyelination, we used C57BL/6-IL-
2ra
2/2 mice as well as depletion of CD25 in C57BL/6 mice using
anti-CD25 mAb. Knockout mice and depleted mice were infected
ocularly with HSV-IL-2 or HSV-IL-4. Fourteen days after
infection, the mice were sacrificed and the ON, SC, and brain
removed, post-fixed and stained with LFB. Representative
photomicrographs of ON, SC, and brain sections from the
knockout and depleted mice infected with HSV-IL-2 or HSV-IL-4
are shown in Figure 8. HSV-IL-2 virus induced demyelination in
ON, SC, and brain of both CD25
2/2 and CD25-depleted mice
(Fig. 8, Left Panels), while mice infected with HSV-IL-4 did not
show any sign of demyelination in their ON, SC, or brain (Fig. 8,
Right Panels). Overall, the number of plaques detected in ON,
Table 1. Summary of LFB staining for presence of
demyelination in ON, SC, and brain of SCID mice following
adoptive transfer.
a
Number of mice with CNS demyelination
following infection with
c
Adoptive transfer
b HSV-IL-2 WT KOS
nCD4
+CD25
+ 0/5 (0%) 0/5 (0%)
nCD4
+CD25
2 5/5 (100%) 0/5 (0%)
nCD8
+CD25
+ 5/5 (100%) 0/5 (0%)
nCD8
+CD25
2 5/5 (100%) 0/5 (0%)
effCD8
+CD25
+ 5/5 (100%) 5/5 (100%)
effCD8
+CD25
2 5/5 (100%) 5/5 (100%)
effCD4
+CD25
+ 5/5 (100%) 0/5 (0%)
effCD4
+CD25
2 5/5 (100%) 5/5 (100%)
Media 0/5 (0%) 0/5 (0%)
aPresence of demyelination in ON, SC, and brain of 5 recipient mice per group
were assessed on day 14 PI.
bNaive T cells (nCD8
+CD25
+, nCD8
+CD25
2, nCD4
+CD25
+, and nCD4
+CD25
2)
were isolated from naive mice, while the effector T cells (effCD8
+CD25
+,
effCD8
+CD25
2, effCD4
+CD25
+, and effCD4
+CD25
2) were isolated from mice
infected with HSV-IL-2 on day 5 PI. Each SCID mice received 2610
5 cells in
300 ml of tissue culture media or tissue culture media only.
cDifferences between group with CNS demyelination versus group with no CNS
demyelination were statistically significant (p=0.008, n=5, Fisher exact test).
doi:10.1371/journal.pone.0016820.t001
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that of wt mice infected with HSV-IL-2 (not shown). These results
were consistent with the results obtained in the adoptive transfer
studies and confirm that HSV-IL-2-induced demyelination can
occur independently of CD25 (IL-2ra).
HSV-IL-2 suppresses IL-12p35 and IL-12p40 transcripts in
BM-derived macrophages
As we have detected an exacerbation of CNS demyelination in
macrophage-depleted mice following ocular infection of mice with
wt HSV-1 (unpublished results), we reasoned that the HSV-IL-2
induced demyelination could be due to suppression of the
macrophages and an associated alteration in the expression of
IL-12p35 and IL-12p40 transcripts. To test this possibility, we
isolated macrophages from BALB/c and C57BL/6 mice and
infected them with 10 PFU/cell of HSV-IL-2 or wt HSV-1, or
mock infected them as we described previously [26]. Previously,
we have shown that macrophages are infected with HSV-1 but the
virus does not replicate in the infected cells [26]. The infected or
mock-infected macrophages were harvested 12, 24, and 48 h PI,
the total RNA was isolated, and IL-12p35 and IL-12p40 mRNAs
levels were quantified by qRT-PCR. We performed TaqMan
qRT-PCR on isolated RNA to determine the amount of IL-12p35
and IL-12p40 mRNAs in infected macrophages relative to levels of
each transcript in the mock-infected macrophages. Cellular
GAPDH mRNA was used as an internal control. Our results
suggest that between 12 h and 48 h PI, the levels of IL-12p35
(Fig. 9, BALB/c) and IL-12p40 (Fig. 9, BALB/c) transcripts in the
HSV-IL-2 infected macrophages was significantly lower than the
levels of these transcripts in the wt HSV-1-infected macrophages.
Similar results were observed in macrophages isolated from
C57BL/6 mice (Fig. 9, C57BL/6). These results suggest that
HSV-IL-2 infection alters the ratio of IL-12p35 and IL-12p40
transcripts in infected macrophages and that this could be a
contributing factor in the development of the T-cell autoimmunity
in the infected mice.
Demyelination in HSV-IL-2-infected mice can be blocked
by injection of IL-12p70 DNA
Our results described above in Figure 9 suggested that HSV-IL-
2 induced demyelination may be associated with an imbalance of
IL-12p70. Thus, the absence of IL-12 function of macrophages
may be the main contributing factor to HSV-IL-2- induced
demyelination and the IL-12p70 arm of macrophage responses
Figure 6. Demyelination in FoxP3
DTR-depleted mice. FoxP3
DTR mice were infected ocularly with HSV-IL-2 or HSV-IL-4. Seventy-two and 24 hrs
prior to infection, and 1, 3, 5, 7, and 9 days PI mice were depleted of their FoxP3 using diphtheria toxin as described previously [69]. After 14 days, ON,
SC and brain were removed, sectioned, and stained for LFB. Arrows indicate areas of demyelination in ON, SC, and brains of HSV-IL-2 infected mice.
doi:10.1371/journal.pone.0016820.g006
Figure. 5. qRT-PCR analyses of FoxP3 transcript in brain of recipient SCID mice. Total RNA from brains of SCID mice described in Fig. 4 and
Table 1 was isolated on day 14 PI. FoxP3 expression in SCID mice infected with the virus and without T cells transfer was used to estimate the relative
expression of FoxP3 transcript in brains of each group of recipient SCID mice. GAPDH expression was used to normalize the relative expression of
each transcript in brain of each group of mice. Each point represents the mean 6 SEM from 3 mice. Panels: A) FoxP3 transcript isolated from SCID
mice received CD4
+ T cells; and B) FoxP3 transcript isolated from SCID mice received CD8
+ T cells.
doi:10.1371/journal.pone.0016820.g005
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hypothesis, we looked at the possibility of whether IL-12p70
injection in HSV-IL-2 infected mice may compensate for the
imbalance of IL-12p35 and IL-12p40 transcripts and thus prevent
demyelination in infected mice. BALB/c mice were immunized
with IL-12p70 DNA or vector DNA and infected 4hr later with
HSV-IL-2. Demyelination in ON, SC, and brain of infected mice
was measured on day 14 PI. Demyelination was not observed in
the ON, SC, and brain of BALB/c mice injected with IL-12p70
DNA (Fig. 10, IL-12p70). However, mice injected with vector
DNA, displayed demyelination in their ON, SC, and brain (Fig. 10,
Vector). Similar result was observed in C57BL/6 mice injected
with IL-12p70 DNA and infected with HSV-IL-2 (not shown).
However, demyelination was not blocked when mice were injected
with IL-23, IL-27, or IL-35 and infected with HSV-IL-2 (not
shown). Thus, our results suggest that demyelination in the CNS of
the HSV-IL-2 infected mice is due to the downregulation of IL-
12p70 expression by the macrophages.
Discussion
In order to mimic the elevation of IL-2 expression that is typical
of MS we have used the neurotropic potential of HSV-1 and the
unique characteristics of the LAT (latency-associated transcript)
promoter that is active in most cell types to extend expression of
murine IL-2 [13]. This model of MS in which mice are infected
with HSV-IL-2 differs from most animal models of MS that are
based on either the autoimmune model [27] or the viral model
[21] in that this model incorporates both viral and immune aspects
of the disease process. Recently, we reported that this recombinant
virus causes CNS demyelination in four different strains of mice
and that the demyelination is more severe in female then male
mice [18]. A summary of the results obtained here with regards to
the mechanism of HSV-IL-2-induced CNS demyelination and
blocking CNS demyelination is presented schematically in
Figure 11. The results of the present study, in which we used
both the BALB/c and C57BL/6 mouse strains, indicate that B-
cells, DCs, and NK cells do not play a role in the HSV-IL-2-
induced demyelination. In contrast, evidence for involvement of
both CD4
+ and CD8
+ T cells in the HSV-IL-2-induced
demyelination was observed using knockout mice, depletion
studies and transfer studies. Moreover, we show that the CD8
+
T cells played a more significant role in HSV-IL-2 induced
demyelination than the CD4
+ T cells. These findings are
consistent with the published data concerning histologic analyses
of specimens obtained from patients with MS at autopsy, which
have shown a possible correlation between the presence of CD4
+
and CD8
+ T cells and the development of demyelinating lesions
[19,20]. The results are also consistent with the reports that
demyelination induced by mouse hepatitis virus (MHV) is
associated with both T cell types [21]. In the EAE model of
MS, it was believed originally that only CD4
+ T cells were
involved in the CNS demyelination [28], but later studies showed
that CD8
+ T cells can also induce demyelination [19].
We extended the studies to evaluate the role of ‘‘naı ¨ve’’ and
HSV-IL-2 ‘‘effector’’ T cells in CNS demyelination using SCID
mice. Based on their constitutive expression of CD25 (the IL-2ra-
chain), T cells can be divided into CD25
+ and CD25
2
Figure 7. Demyelination in STAT4
2/2 and STAT6
2/2 mice. Female STAT4
2/2 and STAT6
2/2 mice were infected ocularly with HSV-IL-2 or HSV-
IL-4 as described in Materials and Methods. After 14 days, ON, SC, and brains were removed, sectioned, and stained for LFB. Arrows indicate areas of
demyelination in ON, SC, and brains of HSV-IL-2 infected mice.
doi:10.1371/journal.pone.0016820.g007
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CD25
+ T cells constitutively express forkhead/winged-helix
transcription factor (Foxp3), recent studies have shown that
CD25
2 T cells also can express FoxP3 [22,30,31]. In the present
study, we show that both CD4
+ and CD8
+ T cells irrespective of
their CD25 status express the FoxP3 gene at equal levels. In line
with the detection of FoxP3 transcript in brain of recipient SCID
mice, our FoxP3 depletion studies suggest that FoxP3 is
contributing to CNS demyelination. Our results suggest that T
cells, whether they express CD25 or not, contribute to the
development of autoimmunity in this model and this could be due
to the fact that both the CD25
+ and CD25
2 cells express similar
levels of FoxP3. FoxP3 expression on Teff T cells is transient and
its expression in Teff cells is not enough to convert them into Treg,
although under repetitive in vitro stimulation this could occur [32].
FoxP3 expression in Teff cells and its maintenance in Treg cells
are both dependent on IL-2 [33,34]. Consequently, in the
presence of IL-2-expressing HSV-1 T cells irrespective of being
regulatory or effector cells all expressing FoxP3 and HSV-IL-2-
induced CNS demyelination is dependent on FoxP3. Thus, our
result is similar to the results of previous studies that suggest that
both CD8
+ Treg [35,36,37] and CD4
+ Treg [38,39,40,41,42] can
cause autoimmunity.
In addition to T cells, macrophages have been implicated in
CNS pathology and MS [43,44]; however, they may play only an
indirect role. The macrophage plays a variety of roles in the
immune defense system, including phagocytosis, tumor cytotoxic-
ity, cytokine secretion and antigen presentation [45,46], as well as
cross-presentation of antigens to naive T cells in vivo [47,48,49]. A
number of factors are known to ‘‘activate’’ or engage macrophages
in these activities, including viral infection. In this study, we show
that HSV-IL-2 infection of macrophages alters the balance of IL-
12p35 and IL12p40 transcripts, which theoretically could favor
the development of autoreactive T cell in the HSV-IL-2 infected
mice. This possibility is supported by our results that showed that
injection of mice with IL-12p70 DNA blocked HSV-IL-2-induced
demyelination. Similar results were obtained when HSV-IL-2
infected mice were also infected with a recombinant HSV-1
expressing IL-12p70 (not shown). Co-infection of mice with HSV-
IL-2 + HSV-IL-12p35, HSV-IL-2 + IL-12p40 alone, or a mixture
did not block demyelination (not shown). Similarly injection of IL-
12p35 DNA alone, IL-12p40 DNA alone, or a mixture did not
block demyelination (not shown). Thus, the in vivo biological
activity of IL-12p70 is dependent on the use of a heterodimer.
Macrophages are the main source of IL-12 production [50,51]. IL-
12 was considered to be a critical cytokine in the pathogenesis of
EAE [52] and later studies showed that although the IL-12p40
component of IL-12 is involved in EAE-induced CNS pathology
this effect is mediated by the binding of the IL-12p40 to IL-23p19
rather than its binding to IL-12p35 [53,54]. Thus, the imbalance
of IL-12p40 and IL-12p35 in the HSV-IL-2 infected mice may be
responsible for a shift in TH1 and TH2 pattern of cytokine
responses as we reported previously [17], and this shift could be
responsible for the development of the autoreactive T cells. This
would be consistent with our detection of demyelination in both
STAT4
2/2 (no TH1 response) and STAT6
2/2 (no TH2 response)
Figure 8. Role of CD25 (IL-2ra) in CNS demyelination. Female C57BL/6 IL-2ra
2/2 mice were infected ocularly with HSV-IL-2 or HSV-IL-4 as
described in Materials and Methods. For CD25 depletion, female C57BL/6 mice were infected ocularly with HSV-IL-2 or HSV-IL-4. Forty-eight hr prior to
infection, and 1, 5, and 9 days PI mice were depleted of CD25 population as described in Materials and Methods. After 14 days, ON, SC, and brains
were removed, sectioned, and stained for LFB. Arrows indicate areas of demyelination.
doi:10.1371/journal.pone.0016820.g008
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STAT6-deficient mice develop a more severe clinical course of
EAE as compared with wild-type or STAT4 knockout mice [55],
while it was reported that IL-2-knockout mice developed less
demyelination compare with their wt counterparts [12]. Thus,
some studies suggest that TH1 cells are protective while other
studies suggest they are pathogenic. These discrepancies could be
due to the use of different antigen, mouse strain, or the methods of
measurement of autoreactivity.
Previously it was shown that IL-2 was essential for the survival
of T regs in vivo [56,57], and exogenous administration of IL-2 can
boost antigen-specific T cell responses and delay the death of
superantigen-reactive T cells [58,59,60]. Furthermore, IL-2/IL-2
mAb complexes also was shown to increase biological activity of
preexisting IL-2 leading to expansion of CD8
+ T cells as well as
CD4
+ T regs in vivo [61]. Our results suggest that constitutive
expression of IL-2 by HSV-IL-2 may prolong the survival of
autoreactive T cells in addition to enhancing the homing of
activated T cells to the CNS. Previously it was shown that nTreg
cells suppress IL-2 mRNA transcription and proliferation of CD4
+
and CD8
+ Teff cells [62]. This could be the reason that in the
present study we did not detect CNS demyelination in SCID mice
that received nCD4
+CD25
+ T cells following ocular infection with
HSV-IL-2. In MS a functional defect of nTreg cells has been
reported [63], despite a frequency of nTrg cells that is similar in
patients and in healthy individuals [64]. Similarly to MS, a normal
number of nTreg cells but with decreased function had been
described in type I diabetes (TID) [65] and in autoimmune
polyglandular syndrome type II [66]. In contrast to CD4
+ T cell
transfer, both naive and effector CD8
+ T cells caused CNS
Figure 9. Level of IL-12p35 and IL-12p40 transcripts in macrophages infected with HSV-IL-2. Subconfluent monolayers of macrophages
from BALB/c and C57BL/6 mice were infected with 10 PFU/cell of HSV-IL-2 or WT HSV-1. Total RNA was isolated 12, 24, and 48hr PI and TaqMan qRT-
PCR was performed using IL-12p35- and IL-12p40-specific primers as described in Materials and Methods. IL-12p35 and IL-12p40 mRNA levels were
normalized in comparison to each transcript in mock-infected macrophages. GAPDH was used as internal control. Each point represents the mean 6
SEM (n=6) from two separate experiments.
doi:10.1371/journal.pone.0016820.g009
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infected mice only effector CD8
+ T cells caused demyelination.
This is similar to the results of previous studies that suggest that
CD8
+ Treg cells can cause autoimmunity [35,36,37].
In addition to the expression of the IL-2 increasing T cell
survival, we find that it also causes an alteration in the IL-12p70
production by macrophages. This alteration in the IL-12p70
component of the macrophage response and increase in T cell
survival in the presence of IL-2 may lead to the development of
autoimmune T cells. In line with the inhibitory effects of HSV-IL-
2 on IL-12p70 function of macrophages, we have shown that
depletion of macrophages also causes CNS demyelination
following ocular infection of depleted mice by wild-type HSV-1.
Similar to this study, demyelination in macrophage depleted mice
can be blocked by IL-12p70 DNA injection (manuscript in
preparation). Thus, our results suggest that communication
between macrophages and T cells via the production of IL-
12p70 by the macrophages acts as a critical suppressor of T-cell
autoreactivity. This inter-relationship between the macrophages
and T cells can be affected by elevated expression of IL-2, which
leads to loss of the suppressive effect; however, the inhibitory
effects of the IL-2 can be restored by IL-12p70 supplementation.
Materials and Methods
Ethics Statement
All animal care and experimental protocols were conducted in
accordance with the regulations of the institutional care and use
committee at the Cedars-Sinai Medical center and the NIH Guide
for the Care and Use of Laboratory Animals (ISBN 0-309-05377-3).
Mice, viruses, and cells
Female BALB/c, BALB/c-STAT4
2/2, BALB/c-STAT6
2/2,
BALB/c-CD19
2/2 (B cell-deficient), BALB/c-SCID, C57BL/6,
C57BL/6-CD4
2/2, C57BL/6-CD8
2/2, and C57BL/6-IL-
12ra
2/2 (CD25-deficient) mice 6-weeks of age were purchased
from the Jackson Laboratory (Bar Harbor, ME). Female
CD19
2/2 (B cell-deficient) and hemizygous C.FVB-Tg (Itgax-
DTR/GFP) 57Lan/J mice on a BALB/c background were
obtained from The Jackson Laboratory, while FoxP3
DTR mice
in C57BL/6 background were a gift from Alexander Y
Rudensky. CD19
2/2, C.FVB-Tg (Itgax-DTR/GFP) 57Lan/J,
and FoxP3
DTR mice were bred at Cedars-Sinai Medical Center.
Six-week-old female BALB/c or C57BL/6 (The Jackson
Laboratory) mice were used as a source of bone marrow (BM)
Figure 10. Blocking demyelination in HSV-IL-2 infected mice by IL-12p70 DNA injection. BALB/c mice were injected IM with IL-12p70 DNA
or vector DNA as described in Materials and Methods. Four hours after the third DNA injected, mice were infected ocularly with HSV-IL-2.
Representative ON, SC and brain sections on day 14 PI from infected mice are shown. The arrows indicate areas of demyelination.
doi:10.1371/journal.pone.0016820.g010
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described previously [26]. Briefly, BM cells were collected by
flushing the femurs with PBS. The cells were pelleted and
resuspended briefly in water to lyse red blood cells then stabilized
by adding complete medium (RPMI 1640, 10% fetal bovine
serum, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-
glutamine). After centrifugation and resuspension in complete
medium supplemented with macrophage-colony stimulator factor
(M-CSF) (100 ng/ml; Peprotech, NJ), the cells were plated in non-
tissue culture plastic Petri dishes (cells from 1 bone per 10 cm dish)
and incubated for 5 days at 37uC with CO2. After 5 days, the
media was removed and the adherent cells were recovered by
incubating the cells with Versene (Invitrogen, San Diego, CA) for
5 min. at 37uC. The cells were washed, counted, and plated onto
tissue-culture dishes for use the following day.
Plaque-purified HSV-1 strains, McKrae (wild type) or KOS and
HSV-1 recombinant viruses expressing IL-2 and IL-4 (HSV-IL-2,
HSV-IL-4) were grown in rabbit skin (RS) cell monolayers in
minimal essential medium (MEM) containing 5% fetal calf serum
(FCS), as described previously [13,14,16]. McKrae virus is virulent
at an infectious dose of 2610
5 plaque forming units (PFU)/eye,
whereas the KOS, HSV-IL-2, HSV-IL12p70 (M002), and HSV-
Figure 11. Proposed mechanism for HSV-IL-2 induced CNS demyelination. The cartoon demonstrates that when mice are infected with
HSV-IL-2 they develop CNS demyelination but when they are co-infected with HSV-IL-2 and IL-12p70 this demyelination is blocked. We propose that
this is caused via the effect of IL-2 on reducing the expression of IL-12p40 in macrophages. Less IL-12p40 means less of the heterodimer IL-12p70
leads to imbalance TH1 response and favors the production of more autoreactive CD4
+FoxP3
+ and CD8
+ FoxP3
+ T cells. Constitutive expression of IL-2
by HSV-IL-2 sustains an active autoreactive CD4
+FoxP3
+ and CD8
+ FoxP3
+ populations. The combination of FoxP3
+ T cells and reduced TH1 leads to
CNS demyelination (left side). In contrast, co-infection of IL-12p70 with HSV-IL2 compensates for the reduction in IL-12p70 caused by IL-2 leading to
functional TH1 populations and reduced demyelination (right side).
doi:10.1371/journal.pone.0016820.g011
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recombinant HSV-IL-2 is expressing IL-2 at high levels in
different tissues [13].
Ocular infection
Mice were infected ocularly with 2610
5 PFU of McKrae, KOS,
recombinant HSV-IL-2, or HSV-IL-4 per eye. Each virus was
suspended in 5 ml of tissue culture media and administered as an
eye drop. In contrast to mice with the C57BL/6 background that
are refractory to McKrae infection, mice with the BALB/c
background are highly susceptible to McKrae infection. Thus,
mice with BALB/c background were infected with KOS rather
then McKrae virus. Corneal scarification was not used.
DNA immunization
The complete open-reading frame (ORF) for IL-12p70 (pORF-
mIL12) was purchased from InvivoGen (San Diego, CA). Plasmid
DNA was purified using cesium chloride gradient. In each
experiment, five mice per group were injected intramuscularly
(IM) (into each of the quadriceps) using a 27 gauge needle with
100 mg of cesium chloride-purified DNA in a total volume of 50 ml
of PBS 3 times. DNA injections were done 14 days, 7 days, and
4 hrs before ocular infection. As a negative control, we used mock-
treated vaccinated mice that were similarly injected with vector
DNA alone.
Depletion of dendritic cells (DCs) and FOxP3
Female BALB/c-DTR mice were depleted of their DCs by
treatment with 100 ng of diphtheria toxin (DT), which was
administered in 100 ml of PBS and injected intraperitoneally as we
described previously [67,68]. Briefly, the mice were administered
DT 24 h before ocular infection, followed by four additional
treatments on days +1, +4, +7, and +10 post infection (PI).
FoxP3
DTR mice were depleted of their FoxP3 by treatment with
DT as described previously [69]. Briefly, the mice were
administered DT 72 and 24 h before ocular infection, followed
by 5 additional treatments on days +1, +3, +5, +7, and +9 PI. This
regimen of treatments reduced each population by more than 97%
as confirmed by FACS analysis of spleen cells 24 hours after the
second depletion as described previously [69].
Depletion of CD4
+ and CD8
+ T cells, and CD25
+ cells
Each mouse received an intraperitoneal injection of 100 mgo f
purified GK1.5 (anti-CD4
+), or 2.43 (anti-CD8
+), or both GK1.5
and 2.43, or PC61.5.3 (anti-CD25) monoclonal antibodies
(NCCC, Minneapolis, MN) in 100 ml of PBS, -5 and -2 days
before ocular infection. The injections were then repeated on days
+1, +4, +7, and +10 relative to ocular infection. Control mice were
depleted with an irrelevant mAb of the same isotype. The
efficiency of CD4
+, CD8
+, and CD25
+ depletion was monitored
by FACS analysis of splenocytes 24 h after the second depletion
and before ocular infection. After the second depletion, more than
95% of CD4+ T cells, CD8+ T cells, or CD25+ T cells were
depleted from the spleens as we described previously [72].
However, based on our results these residual of T cells did not
have any effect on inducing demyelination when both CD4+ and
CD8+ T cells were depleted.
Depletion of NK cells with anti-asialo GM1
One mg of rabbit anti-asialo GM1 antibody (Wako Chemicals,
Dallas, TX) was dissolved in 1 ml of PBS and each mouse received
multiple intraperitoneal injections of 100 mg of antibody in 100 ml
of PBS. The first depletion was done -5 days before ocular
infection and this was followed by five additional depletions on
days 22, +1, +4, +7, and +10 PI as we described previously [70].
After the second depletion, more than 93% of NK cells were
depleted from the spleens as we described previously [70]. Control
mice were treated with an equal concentration of freeze-dried
normal rabbit serum in PBS.
Preparation of ON, SC, and brain for pathologic analysis
The ON, SC, and brain of infected mice were removed at
necropsy on day 14 PI. ON, SC, and brain were collected from
experimental and control mice, then placed in Tissue-TeK OCT
embedding medium (SaKura Fintek, Torrence, CA) and then
stored at –80uC. Transverse sections of each tissue, 8-10 mm thick,
were cut, air-dried overnight, and fixed in acetone for 3 min at
25uC [71]. Demyelination in each section was confirmed by
monitoring adjacent sections.
Analysis of demyelination using Luxol Fast Blue (LFB)
staining
The presence or absence of demyelination in ON, SC, and
brain of infected mice was evaluated using LFB staining of
formalin-fixed sections of ON, SC, and brain as we described
previously [17]. Every 4th section of ON, SC, and brain was
stained with LFB.
Adoptive transfer of T cells
Donor BALB/c mice that were either mock-infected or ocularly
infected with HSV-IL-2 were sacrificed on day 5 PI, the spleens
were pooled, and single-cell suspensions prepared as described
previously [72]. Naive T cells (i.e., nCD4
+CD25
+, nCD4
+CD25
2,
nCD8
+CD25
+, nCD8
+CD25
2) from mock-infected mice, and
effector T cells from HSV-IL-2-infected mice (i.e., effCD4
+CD25
+,
effCD4
+CD25
2, effCD8
+CD25
+, effCD8
+CD25
2) were isolated
using magnetic beads as described by the manufacturer (Miltenyi
Biotec, Auburn, CA). Each recipient SCID mouse was injected
once with 2610
5 cells in 300 ml of MEM intraperitoneally. The
control mice received 300 ml MEM alone. The recipient and
control mice were infected ocularly with KOS or HSV-IL-2 virus
4 h after transfer of the cells.
Infection of BM-derived macrophages in vitro
Bone marrow (BM) for the generation of mouse macrophages in
cultures were isolated by flushing femurs and tibiae with PBS as we
described previously [26]. Monolayers of macrophages isolated
from BALB/c or C57BL/6 mice were infected with 10 PFU/cell
of HSV-1 strain KOS or HSV-IL-2 or mock-infected. One hour
after infection at 37uC, virus was removed and the infected cells
were washed three times with fresh media and fresh media was
added to each well. The monolayers including media were
harvested at 12, 24, and 48 h PI. RNA preparation was done as
we described previously [26]. Briefly, frozen cells were resus-
pended in TRIzol and homogenized, followed by addition of
chloroform, and subsequent precipitation using isopropanol. The
RNA was then treated with DNase I to degrade any contaminat-
ing genomic DNA followed by clean-up using a Qiagen RNeasy
column as described in the manufacturer’s instructions. The RNA
yield from all samples was determined by spectroscopy (NanoDrop
ND-1000, NanoDrop Technologies, Inc., Wilmington, Delaware).
Finally, 1000 ng of total RNA was reverse-transcribed using
random hexamer primers and Murine Leukemia Virus (MuLV)
Reverse Transcriptase from the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA), in
accordance with the manufacturer’s recommendations.
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The expression levels of IL-12p35 and IL-12p40 genes in BM-
derived macrophages and expression of CD4, CD8, and FoxP3 in
brain of recipient SCID mice were evaluated using commercially
available TaqMan Gene Expression Assays (Applied Biosystems,
Foster City, CA) with optimized primer and probe concentrations
as we described previously [73,74]. Cellular GAPDH gene
expression was used as an internal control. Primer-probe sets
consisted of two unlabeled PCR primers and the FAM
TM dye-
labeled TaqMan MGB probe formulated into a single mixture.
The primers and probe used were as follows: 1) IL-12p35 (ABI
ASSAY I.D. Mm00434165_m1 – Amplicon length =68 bp); 2)
IL-12p40 (ABI ASSAY I.D. Mm 01288992_m1 – Amplcon length
=109 bp); 3) GAPDH (ABI ASSAY I.D. m999999.15_G1 -
Amplicon Length =107 bp); and 4) FoxP3 (ABI ASSAY I.D.
Mm00475164_m1 – Amplicon length =80bp).
Quantitative real-time PCR was performed as we described
previously [73]. Real-time PCR was performed in triplicate for
each sample from each time point. Relative gene expression levels
were normalized to the expression of the GAPDH housekeeping
gene (endogenous loading control).
Statistical analysis
Fisher’s exact tests were performed using the computer program
Instat (GraphPad, San Diego) to compare demyelination in
infected mice with the absence of demyelination in control groups.
Results were considered statistically significant when the P value
was ,0.05.
Supporting Information
Figure S1 Severity of CNS demyelination in knockout
and depleted mice infected with HSV-IL-2. The entire
brain, SC and ON of each of the 5 animals described in Figs. 2
and 3 were sectioned and every 4 slides of each tissues were
stained. The numbers of demyelination plaques in the entire
sections of ON, SC and brain were counted. Data are presented as
percent of sections with plaques per total sections stained (number
on each bar graph shows the number of section showing plaques/
total stained section). Panels: A) Percent of plaque/section in
C57BL/6-CD4
2/2, C57BL/6-CD8
2/2, and WT C57BL/6
mice; and B) Percent of plaque/section in CD4-depleted, CD8-
depleted, both CD4- and CD8-depleted, and WT mock depleted
C57BL/6 mice.
(TIF)
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